Most clinical trials fail to reflect America’s racial and ethnic diversity

FDA drug trials exclude a widening slice of Americans, research reveals

A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic makeup, with an increasing trend of trials underrepresenting Black and Hispanic individuals.

FDA Data Shows Stunning Lack Of Diversity In U.S. Drug Trials

The future of medicine is supposed to be personal, but drug trial research suggests modern medicine has a lot of catching up to do in terms of American diversity. The post FDA Data Shows Stunning Lack Of Diversity In U.S. Drug Trials appeared first on Study Finds.

Most clinical trials fail to reflect America’s racial and ethnic diversity

A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic makeup, with an increasing trend of trials underrepresenting Black and Hispanic individuals.

Only 6 Percent of U.S. Drug Approval Trials Reflect Racial and Ethnic Diversity

A recent study reveals that only 6% of clinical trials […] The post Only 6 Percent of U.S. Drug Approval Trials Reflect Racial and Ethnic Diversity first appeared on GeneOnline News. The post Only 6 Percent of U.S. Drug Approval Trials Reflect Racial and Ethnic Diversity appeared first on GeneOnline News.

Only 6% of FDA Pivotal Trials Reflect U.S. Racial Makeup

A new analysis from researchers at UC Riverside and UC Irvine found that only six percent of pivotal trials conducted to gain approval for new drugs from the U.S. Food and Drug Administration (FDA) between 2017 and 2023 reflected the racial and ethnic makeup of the U.S. population. The study, published in Communications Medicine, showed that there is a trend of declining enrollment of Black and Hispanic participants beginning in 2021 and cited s…